Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:13 PM
Ignite Modification Date:
2025-12-24 @ 10:13 PM
NCT ID:
NCT04127435
Eligibility Criteria:
Inclusion Criteria:
* Patients with histologically confirmed pelvic recurrence of cervical cancer.
* Age ≥ 18 years and ≤ 75 years.
* Previous accept pelvic radiotherapy;
* Karnofsky ≥60；
* Patients reject or cannot tolerate surgery;
* Received 192Ir high dose rate intertissue salvage therapy;
* Ultrasound guidance or computed tomography guidance;
* Regular review and follow-up.
Exclusion Criteria:
* Patients participated in clinical trials of other drugs within four weeks;
* The patient had a previous history of bleeding, and any bleeding event with severity rating of CTCAE5.0 or above occurred within 4 weeks prior to screening;
* There are any puncture taboos.
* Patients with severe cardiovascular and cerebrovascular diseases.
* Unable to treat as planned.
* Patients lack major indicators and cannot participate in post-treatment review and follow-up.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT04127435
Study Brief:
Protocol Section:
NCT04127435